These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases. Abbracchio MP; Cattabeni F Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415 [TBL] [Abstract][Full Text] [Related]
5. Adenosine extracellular brain concentrations and role of A2A receptors in ischemia. Pedata F; Corsi C; Melani A; Bordoni F; Latini S Ann N Y Acad Sci; 2001 Jun; 939():74-84. PubMed ID: 11462806 [TBL] [Abstract][Full Text] [Related]
6. Low doses of the selective adenosine A2A receptor agonist CGS21680 are protective in a rat model of transient cerebral ischemia. Melani A; Corti F; Cellai L; Vannucchi MG; Pedata F Brain Res; 2014 Mar; 1551():59-72. PubMed ID: 24457041 [TBL] [Abstract][Full Text] [Related]
7. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? von Lubitz DK Eur J Pharmacol; 1999 Apr; 371(1):85-102. PubMed ID: 10355598 [TBL] [Abstract][Full Text] [Related]
9. Adenosine A2A receptors and neuroprotection. Ongini E; Adami M; Ferri C; Bertorelli R Ann N Y Acad Sci; 1997 Oct; 825():30-48. PubMed ID: 9369973 [TBL] [Abstract][Full Text] [Related]
11. The Selective Antagonism of Adenosine A Fusco I; Ugolini F; Lana D; Coppi E; Dettori I; Gaviano L; Nosi D; Cherchi F; Pedata F; Giovannini MG; Pugliese AM Front Pharmacol; 2018; 9():399. PubMed ID: 29740323 [TBL] [Abstract][Full Text] [Related]
12. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? Von Lubitz DK Eur J Pharmacol; 1999 Jan; 365(1):9-25. PubMed ID: 9988118 [TBL] [Abstract][Full Text] [Related]
13. The adenosine neuromodulation system in schizophrenia. Rial D; Lara DR; Cunha RA Int Rev Neurobiol; 2014; 119():395-449. PubMed ID: 25175974 [TBL] [Abstract][Full Text] [Related]
14. [Importance of adenosine A2A receptors in resistance to complete global cerebral ischemia]. Kulinskiĭ VI; Minakina LN; Usov LA Eksp Klin Farmakol; 2000; 63(6):9-11. PubMed ID: 11202519 [TBL] [Abstract][Full Text] [Related]
15. Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells. Marquardt DL; Walker LL; Heinemann S J Immunol; 1994 May; 152(9):4508-15. PubMed ID: 8157966 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective role of adenosine in the CNS. Wardas J Pol J Pharmacol; 2002; 54(4):313-26. PubMed ID: 12523485 [TBL] [Abstract][Full Text] [Related]
17. Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists. Schindler CW; Karcz-Kubicha M; Thorndike EB; Müller CE; Tella SR; Ferré S; Goldberg SR Br J Pharmacol; 2005 Mar; 144(5):642-50. PubMed ID: 15678095 [TBL] [Abstract][Full Text] [Related]
18. Adenosine and neuroprotection. Fredholm BB Int Rev Neurobiol; 1997; 40():259-80. PubMed ID: 8989624 [TBL] [Abstract][Full Text] [Related]
19. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration. Stone TW; Ceruti S; Abbracchio MP Handb Exp Pharmacol; 2009; (193):535-87. PubMed ID: 19639293 [TBL] [Abstract][Full Text] [Related]
20. Distribution of adenosine A1, A2A and A2B receptors in human skeletal muscle. Lynge J; Hellsten Y Acta Physiol Scand; 2000 Aug; 169(4):283-90. PubMed ID: 10951119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]